Comparison between Phoenix system and agar-based methods for antimicrobial susceptibility testing of Streptococcus spp;Comparación entre el sistema Phoenix y métodos basados en agar para el ensayo de sensibilidad a antibióticos en Streptococcus spp

Revista Espanola de Quimioterapia

Volumn 21, Issue 3, 2008, Pages 184-188

  Martinez Lamas L ^a   Treviño Castellano, Mercedes ^a   Romero Jung, P A ^a   Regueiro Garcia B J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Antimicrobial susceptibility testing; Disk diffusion; ETest; Phoenix; Streptococcus

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; VANCOMYCIN;

AGAR DIFFUSION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISK DIFFUSION; EPSILOMETER TEST; INTERMETHOD COMPARISON; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; NONHUMAN; QUANTITATIVE ASSAY; SENSITIVITY ANALYSIS; SPECIES DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

AGAR; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS;

EID: 55049119396     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnik AH. Antimicrobial susceptibility patterns of β-haemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002;43:57-162.
2. Brigante GR, Luzzaro FA, Pini B, Lombarda G, Sokeng G, Toniolo AQ. Drug susceptibility testing clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system. BMC Microbiology 2007;7:46.
3. Biedenbach D, Toleran MA, Walsh TR, Jones RN. Characterization of fluoroquinolone-resistant β-haemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluorquinolone resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006;55:119-27.
4. Clinical Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing. Seventeenth informational supplement M100-S17. Wayne, PA: Clinical and Laboratory Standard Institute, 2007.
5. Spellerberg B, Brandt C. Streptococcus. En: Murray PR, editor. Manual of clinical microbiology, vol 1. Washington: ASM Press, 2007; p. 412-29.
6. Thornsberry C, Anhalt JP, Washington II JA, McCarthy LR, Schoenknecht FD, Sherris JC, et al. Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J Clin Microbiol 1980;12:375-90.
7. Kanemitsu K, Kunishima H, Inden K, Hatta M, Harigae H, Ishizawa K, et al. Evaluation of the BD Phoenix SMIC/ID, a new streptococci identification and antimicrobial susceptibility panel, for potential routine use in a university-based clinical microbiology laboratory. Diagn Microbiol Infect Dis 2005;53:101-5.
8. National Committee for Clinical Laboratory Standards: development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline-second edition. Document M23-A2. Wayne, Pa: National Committee for Clinical Laboratory Standards, 2001.
9. Food and Drug Administration, 5 March 2007. Class II Special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry FDA. Rockville: Food and Drud Administration, 2007.
10. Richter SS, Howard WJ, Weinstein MP, Bruckner DA, Hindler, Saboulle JM, et al. Multicenter evaluation of the BD Phoenix automated microbiology system for antimicrobial susceptibility testing of Streptococcus species. J Clin Microbiol 2007;45: 2863-71.
11. Hirakata Y, Matsuda J, Nakano M, Hayashi T, Tokaza S, Takezawa T, et al. Evaluation of the BD Phoenix automated microbiology system SMIC/ID panel for identification and antimicrobial suscepyibility testing of Streptococcus spp. Diagn Microbiol Infect Dis 2005;53:169-73.